Clinical trial

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

NCT01519700

Study summary

ClinicalTrials.gov

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention EP2006 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Filgrastim Normalized identity: filgrastim View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-12-01

PhasePHASE3

Conditions

Chemotherapy Associated Neutropeniaunresolved

Breast Cancerverified · MONDO: breast cancer

Interventions

EP2006DRUG

FilgrastimDRUG · verified · RxNorm: filgrastim

Sponsors & collaborators

Sandozlead sponsor

Mapped research locations

BudapestHungary2 Saint PetersburgRussia2 MoscowRussia1 DebrecenHungary1 LvivUkraine1 OdesaUkraine1 Nizhny NovgorodRussia1 ChelyabinskRussia1 NyíregyházaHungary1 DnipropetrovskUkraine1 SzékesfehérvárHungary1 SzombathelyHungary1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01519700 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.